Latest Security News

DMC Mining Limited reports steady progress on its Guinea projects’ licences amid ongoing ASX re-admission efforts, despite critically low cash reserves.

Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.

Arafura Rare Earths has launched a major A$475 million placement alongside a A$50 million share purchase plan, significantly advancing funding for its Nolans Project and edging closer to a Final Investment Decision in early 2026.

Macro Metals Limited has bolstered its financial position with a $2 million capital raise while making significant progress across its iron ore and construction sand projects, underpinned by strong Indigenous joint ventures and mining services development.

Klevo Rewards Limited reports a strong quarter with a tenfold increase in customer receipts and positive cash flow, completing a $3.4 million entitlement offer and advancing steps toward ASX reinstatement.

Taiton Resources has successfully issued 5 million new shares to sophisticated investors, marking the completion of its Tranche 1 placement and reinforcing its funding position for key mineral projects.

Tesoro Gold Limited has announced plans for a 15-for-1 share consolidation aimed at simplifying its capital structure and enhancing its appeal to investors, pending shareholder approval at the November 26 meeting.

Assetora Limited has reopened its flagship fund under a new name, secured a $3 million strategic investment, and reported its first positive operating cashflow since adopting its fund-management model.

Carbonxt Group Limited has advanced its Kentucky activated carbon facility ownership to 45.9%, with kiln commissioning underway and a projected 200% sales increase. The company also raised $1.3 million to support growth amid strong regulatory demand for PFAS filtration products.

DMC Mining Group reported a modest cash outflow for the September quarter while securing a loan facility variation and initiating a $6 million capital raise to support its exploration ambitions.

Radiopharm Theranostics has secured FDA approval to initiate a Phase I trial targeting B7H3 and raised A$40 million to accelerate its radiopharmaceutical programs. The company also appointed renowned oncologist Dr Oliver Sartor to its Scientific Advisory Board.

Domino’s Pizza Enterprises has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed acquisition talks despite market speculation.